Ledger.Open graph →
SEC Form D · filed August 28, 2017

Thrive Bioscience, Inc

Offering
$2.5M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Wakefield, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Christy Ai · San Francisco, CADirectorAngelique-Johanna I. Brandt · Sneek, P7Exec · DirectorPaul Crowley · BOSTON, MADirectorFranklin D. Myers · Sneek, P7DirectorBCCM Advisors, LLC · Minneapolis, MNExec · DirectorKenneth Ray · York, MEExec · DirectorPaul Turek · San Francisco, CAExec · DirectorFiona M. Darmon · Jerusalem, L3DirectorYoav M. Tzruya · Jerusalem, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗